scstocks,
I certainly appreciate your polite response. The odds appear to be in your favor. Although I have been in COR since 1996, I have never followed this company as closely as I have as of late.
It seemed to me that even though a poor financing deal had taken place as a safety net, the funds that were sure to come from the CX717 acceptance and an eminant BP deal appeared to be financially vital to bring other compounds forward.
I too buy on bad news and try to sell on good, this ussually in a stable non-bio environment, however, COR has not offered me this luxury. I did have a chance to make lofty profit after my first 50K reentry @ $1.14 prior to Stoll's post mortem press release. I accumulated much more on certain future good news which came in spurts but the gamebreaker never did surface. I believed in Stoll's confidence, and this board's as well, and now am severly underwater. I only blame myself. I have sat on the sidelines of this board but am now looking for answers from those who did offer their stongest confidence in CX717 ADHD approval.
As I stated, I am not a chemist or compound technical savy but I do understand that without the revealing of the so called irons currently in the fire we are a bobber with a hole in it.....soon to sink. There maybe bottom feeders offering unatractive financing deals keeping COR afloat but what does that do for the share holder...zip. I am anxious to see the writing on those pokers....when my faith is restored I will move quietly back to the sidelines and take in the technical thoughts of those who deserve to speak on such matters, but for now I am looking for a satisfying answer from our board of experts as to what may come of our cash and events which lie ahead. Good luck to you as well. I am trying to remain positive.